Fortress Biotech (FBIO) Income from Non-Controlling Interests (2015 - 2026)

Fortress Biotech's Income from Non-Controlling Interests history runs 11 years deep, the most recent figure standing at -$78.0 million for Q4 2025.

• In Q4 2025, Income from Non-Controlling Interests fell 298.98% year-over-year to -$78.0 million; the TTM figure through Dec 2025 stood at -$94.0 million (down 240.02% YoY), while the FY2025 annual figure was -$39.7 million, up 46.93% from the prior year.
• Income from Non-Controlling Interests for Q4 2025 stood at -$78.0 million, down from -$3.0 million in the prior quarter.
• The five-year high for Income from Non-Controlling Interests was $36.9 million in Q4 2021, with the low at -$224.2 million in Q4 2022.
• The 5-year median for Income from Non-Controlling Interests is -$15.5 million (2021), against an average of -$17.3 million.
• The sharpest annual moves came in 2021 and 2022: Income from Non-Controlling Interests soared 343.13% in 2021, then slumped 706.82% in 2022.
• Fortress Biotech's Income from Non-Controlling Interests stood at $36.9 million in 2021, then plunged by 706.82% to -$224.2 million in 2022, then jumped by 108.79% to $19.7 million in 2023, then slumped by 199.21% to -$19.6 million in 2024, then tumbled by 298.98% to -$78.0 million in 2025.
• Business Quant data shows FBIO's Income from Non-Controlling Interests at -$78.0 million in Q4 2025, -$3.0 million in Q3 2025, and -$27.1 million in Q2 2025.